Activation of the ABL1 gene along with the NUP214::ABL1 fusion is associated with the TLX1 and TLX3 subgroup [30] while ABD is an established marker of the ETP-ALL subgroup of T-ALL [11]. The gene discussed is TLX3; the disease is acute lymphoblastic leukemia.